Quarterly Spotlight Corporate Venture Capital Deal Analysis - Q2 2025

Corporate Venture Capital (CVC) deal activity declined in Q2, as funds maintained a cautious approach and continued to focus on established companies within innovation-driven industries.

The second quarter of 2025 witnessed a stable pace of deal-making by Corporate Venture Capital (CVC) funds, with 948 deals recorded globally. However, despite consistent activity, capital deployed fell to approximately $21 billion, reflecting a 30% decline compared to Q1 2025 — signaling a more cautious investment approach amid evolving macroeconomic dynamics.

North America and Asia continued to lead CVC activity, jointly accounting for ~77% of total investments. Funding remained focused on later-stage rounds, which drew nearly 39% of total capital, while early-stage companies attracted a smaller share at just 8%.

From a sectoral lens, software, computer hardware, pharmaceuticals, and commercial products dominated investor interest — collectively representing 62% of total CVC funding during the quarter. Additionally, the quarter’s most active CVC funds, including those backed by Coinbase Global and Alphabet, completed a combined 62 deals.

This report highlights key trends in deal volume, capital deployment, investment stage preferences, sectoral patterns, and the top 50 transactions that shaped the CVC landscape in Q2 2025.